In contrast, oe-Foxa2 transfection suppressed the levels of AST, ALT, TG, and TC in HFD-stimulated NAFLD mice (P < 0.01; Figs. 2A–2B). This evidence concerns the gene FOXA2 and metabolic dysfunction-associated steatotic liver disease.